546085-37-4 Usage
Uses
Used in Pharmaceutical Synthesis:
(4-Benzyl-piperidin-4-yl)-methanol is utilized as a key building block in the synthesis of various pharmaceuticals. Its chemical structure allows for the creation of a range of bioactive molecules, making it a valuable asset in the development of new drugs and therapeutic agents.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (4-benzyl-piperidin-4-yl)-methanol serves as an essential component in research studies. Its properties and reactivity contribute to the understanding of molecular interactions and the design of novel compounds with potential therapeutic applications.
Used in Drug Discovery Efforts:
(4-benzyl-piperidin-4-yl)-methanol's versatility and unique structure make it a promising candidate for drug discovery efforts. Researchers can leverage (4-benzyl-piperidin-4-yl)-methanol to develop new drugs and therapeutic agents that target specific biological pathways or receptors, potentially leading to more effective treatments for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 546085-37-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,4,6,0,8 and 5 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 546085-37:
(8*5)+(7*4)+(6*6)+(5*0)+(4*8)+(3*5)+(2*3)+(1*7)=164
164 % 10 = 4
So 546085-37-4 is a valid CAS Registry Number.
546085-37-4Relevant academic research and scientific papers
THERAPEUTIC COMPOUNDS AND COMPOSITIONS
-
Paragraph 0797; 0800, (2014/09/30)
Compounds of general formula I: and compositions comprising compounds of general formula I that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.
THERAPEUTIC COMPOUNDS AND COMPOSITIONS
-
, (2014/09/29)
Compounds of general formula (I) and compositions comprising compounds of general formula I that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.
THERAPEUTIC COMPOUNDS AND COMPOSITIONS
-
, (2014/09/29)
Compounds of general formula (I) and compositions comprising compounds of general formula (I) that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.
Substituted benzothiazole amide derivatives
-
, (2008/06/13)
A compound of formula I and a method of treatment of diseases, related to modulation of the adenosine A2 receptor system comprising administering a compound of formula 1to a person in need of such treatment.
